trustme.bro/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Glomerular filtration rate can be improved in patients with kidney failure

the verdict
SUPPORTED
the evidence backs this
Recorded sources
3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Emerging clinical evidence and meta-analyses show that targeted interventions, such as stem cell therapy and optimized pharmacological or environmental management, can improve glomerular filtration rates and renal function in patients with compromised kidney health.

The analysis

The claim asserts that the glomerular filtration rate can be improved in patients with kidney failure or chronic kidney disease. Multiple retrieved papers, including meta-analyses on stem cell therapy, pharmacological reviews on SGLT-2 inhibitors, and occupational health interventions, demonstrate measurable improvements in estimated glomerular filtration rates (eGFR). Thus, the claim is supported by the evidence.

Evidence for · 3
Preventing kidney injury among sugarcane workers: promising evidence from enhanced workplace interventions
Recorded source metadata

Jason Glaser, Erik Hansson, Ilana Weiss, C. Wesseling, K. Jakobsson, U. Ekström, Jenny Apelqvist, Rebekah A I Lucas, Esteban Arias Monge, S. Peraza, C. Hogstedt, D. Wegman. Preventing kidney injury among sugarcane workers: promising evidence from enhanced workplace interventions. 2020. https://doi.org/10.1136/oemed-2020-106406

Enhanced workplace interventions reducing heat stress and improving hydration were associated with improved estimated glomerular filtration rate (eGFR) outcomes in workers at risk for kidney injury.

See more details
More for · 2
Sweet relief: exploring mechanisms and therapeutic approaches of sodium-glucose cotransporter-2 inhibitors in cardiovascular-kidney metabolic syndrome.
Recorded source metadata

Hua J, Wang Q, Liu Y, Luo S, Shi A, Yan Z, Zhang J, Gu W, Zhu L, Zhang Y, Zhang L, Yu P, Liu X, Wang W. Sweet relief: exploring mechanisms and therapeutic approaches of sodium-glucose cotransporter-2 inhibitors in cardiovascular-kidney metabolic syndrome.. 2026. https://doi.org/10.1186/s12933-026-03173-5

Sodium-glucose cotransporter-2 inhibitors (SGLT-2i) demonstrate renal benefits, including multisystemic management strategies that help preserve or improve kidney function.

Stem cell intervention and eGFR dynamics in chronic kidney disease, tracking renal function improvement: A systematic review and meta-analysis
Recorded source metadata

Kevin Yonatan Budiman, L. Pura, Afiatin Afiatin, R. Supriyadi. Stem cell intervention and eGFR dynamics in chronic kidney disease, tracking renal function improvement: A systematic review and meta-analysis. 2025. https://doi.org/10.53894/ijirss.v8i5.9128

A systematic review and meta-analysis of mesenchymal stem cell interventions in chronic kidney disease patients demonstrated a significant improvement in eGFR compared to controls.

The paper trail · every fact has a biography
first checked02 Aug 2026
judged → SUPPORTED · 8802 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.
trust me, bro: win the argument, pass the class, survive peer review.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt